This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
million fewer doses were administered in retail and clinical settings than in the prepandemic 2019-2020 season. Additionally, vaccination rates among Medicare beneficiaries 65 years and older reached only 48.3%, and nearly 9.2
Decline in receipt of vaccines by Medicare beneficiaries during the COVID-19 pandemic—United States, 2020. Last Updated October 4, 2024. Accessed July 23, 2025. Hong K, Zhou F, Tsai Y, et al. MMWR Morb Mortal Wkly Rep. 2021;70:245-249. doi:10.15585/mmwr.mm7007a4. Kar A, Carrel AL, Miller JH, Le HTK.
Updated June 15, 2020. 9 If a situation warrants measurement of DOAC levels, such as a major bleeding event or concern about drug accumulation, the preferred test to quantify the anticoagulant effects would be anti–factor Xa activity calibrated specifically for the DOAC being measured. REFERENCES Rivaroxaban. MedlinePlus. link] Edoxaban.
2019;380:2020-2030. doi:10.1056/NEJMoa1901963 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Global Initiative for Asthma. Accessed June 9, 2025. Beasley R, Holliday M, Reddell HK, et al. N Engl J Med.
Data collection spanned January 2020 to March 2023. This study examines herbal supplement prevalence, pharmacist interventions, and their impact on oncology treatment safety. Materials and Methods A survey-based observational study was conducted at the UC Davis Comprehensive Cancer Center.
Insani WN, Qonita NA, Jannah SS, et al. Improper disposal practice of unused and expired pharmaceutical products in Indonesian households. 2020;6(7):e04551. doi:10.1016/j.heliyon.2020.e04551 What to do with unwanted household medicines. United States Environmental Protection Agency. Updated March 28, 2025. Accessed June 6, 2025. Take Back Day.
Signal Transduction Targeted Therapy 2020; 5:101. HALO: results from a phase 2 double-blind, placebo-controlled trail evaluating the efficacy and safety of baxdrostat in patients with uncontrolled hypertension. Presented at ACC/WCC 2023. March 4, 2023. New Orleans. Hu B, Zhong L, Weng Y, et al. Therapeutic siRNA: state of the art.
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Arthritis Care Res ( Hoboken ). 2021;73(1):1-9.
trillion economic impact in 2020. trillion economic impact in 2020. trillion economic impact in 2020. trillion (about $4600 per capita in the US) in 2020. LIMITX technology, developed by Abuse Deterrent Pharma and Acura Pharmaceuticals, controls drug release to reduce overdose risk.
While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. 1991;68(3):499-501. doi:10.1002/1097-0142(19910801)68:3 3.0.co;2-f European Medicines Agency. Accessed July 21, 2025. link] NHS England.
The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. September 13, 2020. Trump to pitch sweeping Medicare drug price plan. May 7, 2025. Accessed May 13, 2025.
Patients with ankylosing spondylitis may be able to receive the same benefits as reference adalimumab (Humira; AbbVie) at a lower cost by using IBI303 (Innovent Biologics), a biosimilar, wrote authors of research published in Medicine (Baltimore).
Pharmacists are essential in managing access, patient education, and monitoring outcomes, ensuring adherence and addressing administrative challenges. On February 21, 2020, the FDA approved eptinezumab-jjmr (Vyepti; Lundbeck) as the first intravenous migraine preventative treatment for adults.
At the American Association of Psychiatric Pharmacists 2025 Annual Meeting in Salt Lake City, Utah, Kayla Johnson, PharmD, BCPS, BCPP, presented on the management of TD with VMAT2 inhibitors in greater detail.
Updated January 22, 2020. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. months versus 7.79 months with tislelizumab. months versus 7.79 months with tislelizumab. Accessed June 25, 2025.
Carey: We know that medication management is a troubling problem, and that's really in part because patients can experience a barrier during any point of their medication journey. Common barriers that I think of include access and cost, but also treatment complexity and forgetfulness.
Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. SHOW MORE The study found biosimilar initiation rose to nearly 42% from 2016 to 2023.
Updated May 6, 2020. link] Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry, January 2018. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024. Accessed June 9, 2025.
Using data from the National Cancer Database, they performed a retrospective analysis on patients diagnosed with metastatic HR–/HER2+ breast cancer between January 2013 and December 2020. 031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). 3 Among the patients, approximately 75.8%
Supreme Court’s decision not to review a pharmacy benefit manager reform case out of Oklahoma: “After the historic Rutledge v. Douglas Hoey on the U.S.
13510 Nutrition Counseling Coverage Act of 2021, HR 6971, 116th Cong (2019-2020). link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Clinical interventions for food-drug interactions: a pharmacist’s perspective.
August 5, 2020. Study of single agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone (Pom/Dex) in participants with relapsed/refractory multiple myeloma (RRMM) (DREAMM-3). Updated June 10, 2025. Accessed June 27, 2025. FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma.
As dictated by the process provided for in the 2020 CARES Act, FDA announced issuance of the proposed order in a Federal Register notice and published the proposed order itself on FDA’s website. Comments on the proposed order are due May 25, 2025.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content